is oral glp 1 fda approved Novo Nordisk's Wegovy® pill (oral semaglutide 25 mg, once daily) has just been by the US as the first GLP‑1 receptor agonist for long‑term weight management and CV risk FDA Approves First-Of-Its-Kind Oral GLP-1

W.GreigN

What makes Semaglutide GLP-1 even more appealing is its convenience it requires only a once-weekly dose via subcutaneous injections or a pen injector

One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes

Butyrate and P9 stimulate GLP-1, the hormone that tells your pancreas to produce insulin, and slows down the emptying of your stomach

GLP-1 drugs are not antidepressants